We measured the levels of cobalt and chromium in the serum in three groups of patients after uncemented porous-coated arthroplasty. Group 1 consisted of 14 consecutive patients undergoing revision for aseptic loosening. Group 2 comprised 14 matched patients in whom the arthroplasty was stable and group 3 was 14 similarly matched patients with arthritis awaiting hip replacement. Specimens were analysed using atomic absorption spectrophotometry. Aseptic loosening of a component resulted in a significant elevation of serum cobalt (p < 0.05), but not of serum chromium. The relative risk of a component being loose, if the patient had a serum cobalt greater than 9.0 nmol/l, was 2.8.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Common Problems Encountered During the Delivery of New Dentures Constructed by Dental Clinical Students at University Sains Islam Malaysia (USIM).
Cureus
December 2024
Anatomy, Universiti Sains Islam Malaysia, Kuala Lumpur, MYS.
Background Dentures are one of the main treatments dentists deliver to restore the oral function and aesthetics of individuals with missing teeth. Clinical denture fabrication and manufacturing is one of the main training modules for undergraduates during dental clinical training. However, students often face problems during denture delivery due to multiple factors causing discomfort to patients, affecting the quality of the denture and the patient's adaptation period to the denture.
View Article and Find Full Text PDFInvestigating residual trace metals in recombinant monoclonal antibodies to facilitate drug development with LC-UV-ICPMS-HRMS.
Anal Chim Acta
February 2025
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 10591-6707, USA.
Background: The biopharmaceutical industry is increasingly interested in the analysis of trace metals due to their significant impact on product quality and drug safety. Certain metals can potentially accelerate the formation of degradants or aggregates in biotherapeutic proteins, leading to drug product quality concerns. A better understanding of metal-mAb interactions would aid in the development of purification processes and formulations, thereby ensuring better drug quality and safety.
View Article and Find Full Text PDFBiomechanical behavior of titanium, cobalt-chromium, zirconia, and PEEK frameworks in implant-supported prostheses: a dynamic finite element analysis.
BMC Oral Health
January 2025
Department of Prosthodontics, Faculty of Dentistry, Hacettepe University, 06230, Sıhhiye/Altındağ, Ankara, Turkey.
Background: The mechanical properties of framework materials significantly influence stress distribution and the long-term success of implant-supported prostheses. Although titanium, cobalt-chromium, zirconia, and polyether ether ketone (PEEK) are widely used, their biomechanical performance under dynamic loading conditions remains insufficiently investigated. This study aimed to evaluate the biomechanical behavior of four framework materials with different Young's modulus using dynamic finite element stress analysis.
View Article and Find Full Text PDFA Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents: The BIOHEART-II Trial.
JACC Cardiovasc Interv
January 2025
Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, Beijing, China. Electronic address:
Background: First-generation bioresorbable scaffolds (BRS) increased risks of stent thrombosis and adverse events. The Bioheart scaffold is a new poly-L-lactic acid-based BRS.
Objectives: This study sought to evaluate the efficacy and safety of the BRS in patients with coronary artery disease.
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial Program.
JACC Cardiovasc Interv
January 2025
Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address:
Background: The risk-benefit ratio of the Absorb bioresorbable vascular scaffold (BVS) may vary before and after 3 years, the time point of complete bioresorption of the poly-L-lactic acid scaffold.
Objectives: The aim of this study was to determine the time-varying outcomes of the Absorb BVS compared with cobalt-chromium everolimus-eluting stents (EES) from a large individual-patient-data pooled analysis of randomized trials.
Methods: The individual patient data from 5 trials that randomized 5,988 patients undergoing percutaneous coronary intervention to the Absorb BVS vs EES with 5-year follow-up were pooled.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!